Zoloft and Adenoma benign - a phase IV clinical study of FDA data

Summary:

Adenoma benign is reported as a side effect among people who take Zoloft (sertraline hydrochloride), especially for people who are female, 60+ old, also take Aredia, and have Breast cancer.

The phase IV clinical study analyzes which people have Adenoma benign when taking Zoloft. It is created by eHealthMe based on reports of 128,159 people who have side effects when taking Zoloft from the FDA, and is updated regularly.

What is Zoloft?

Zoloft has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 138,798 Zoloft users. Check the latest studies of Zoloft.

What is Adenoma benign?

Adenoma benign (non-cancerous tumour -secreting) is found to be associated with 330 drugs and 357 conditions by eHealthMe. Check the latest studies of Adenoma benign.

On Aug, 01, 2026

128,159 people reported to have side effects when taking Zoloft.
Among them, 60 people (0.05%) have Adenoma benign.

Among these 60 people:

What is the gender of people who have Adenoma benign when taking Zoloft? *

female: 86.67 %
male: 13.33 %

What is the age of people who have Adenoma benign when taking Zoloft? *

What are other drugs people take besides Zoloft? *

What are other side effects people have besides Adenoma benign? *

Fatigue (feeling of tiredness): 44 people, 73.33%
Atelectasis (partial or complete collapse of the lung): 34 people, 56.67%
Anaemia (lack of blood): 33 people, 55.00%
High Blood Pressure: 33 people, 55.00%
Bone Disorder: 32 people, 53.33%
Osteonecrosis Of Jaw (death of bone of jaw): 31 people, 51.67%
Pneumonia: 30 people, 50.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 29 people, 48.33%
Periodontal Disease (disease that attacks the gum and bone and around the teeth): 26 people, 43.33%
Osteomyelitis (infection of bone): 26 people, 43.33%

What are the existing conditions these people have? *

Breast Cancer: 17 people, 28.33%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 15 people, 25.00%
High Blood Pressure: 15 people, 25.00%
Pain: 15 people, 25.00%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 11 people, 18.33%
Metastases To Bone (cancer spreads to bone): 11 people, 18.33%
Anaemia (lack of blood): 6 people, 10.00%
Menopause (end of monthly cycles in women): 1 person, 1.67%
Thyroid Diseases: 1 person, 1.67%
Disturbance In Attention: 1 person, 1.67%

* Approximation only. Some reports may have incomplete information.

Do you take Zoloft and have Adenoma benign?

- Check whether Adenoma benign is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zoloft:

Zoloft (138,798 reports)

Adenoma benign treatments and more:

Adenoma benign (1,464 reports)

Browse all side effects of Zoloft:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Adenoma benign:

Adenoma benign (330 drugs)

Browse all the conditions that are associated with Adenoma benign:

Adenoma benign (357 conditions)

Related publications that referenced our studies

Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on sertraline hydrochloride (the active ingredients of Zoloft) and Zoloft (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.